APA
Yang H., Yeh M., Wong G. L., Peng C., Chen C., Trinh H. N., Cheung K., Xie Q., Su T., Kozuka R., Lee D., Ogawa E., Zhao C., Ning H., Huang R., Li J., Zhang J. Q., Ide T., Xing H., Iwane S., Takahashi H., Wong C., Wong C., Lin C., Hoang J., Le A., Henry L., Toyoda H., Ueno Y., Gane E. J., Eguchi Y., Kurosaki M., Wu C., Liu C., Shang J., Furusyo N., Enomoto M., Kao J., Yuen M., Yu M. & Nguyen M. H. (20200921). Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral Therapy. : The Journal of infectious diseases.
Chicago
Yang Hwai-I, Yeh Ming-Lun, Wong Grace L, Peng Cheng-Yuan, Chen Chien-Hung, Trinh Huy N, Cheung Ka-Shing, Xie Qing, Su Tung-Hung, Kozuka Ritsuzo, Lee Dong-Hyun, Ogawa Eiichi, Zhao Changqing, Ning Hui-Bin, Huang Rui, Li Jiayi, Zhang Jian Q, Ide Tatsuya, Xing Huichun, Iwane Shinji, Takahashi Hirokazu, Wong Christopher, Wong Clifford, Lin Chia-Hsin, Hoang Joseph, Le An, Henry Linda, Toyoda Hidenori, Ueno Yoshiyuki, Gane Edward J, Eguchi Yuichiro, Kurosaki Masayuki, Wu Chao, Liu Chenghai, Shang Jia, Furusyo Norihiro, Enomoto Masaru, Kao Jia-Horng, Yuen Man-Fung, Yu Ming-Lung and Nguyen Mindie H. 20200921. Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral Therapy. : The Journal of infectious diseases.
Harvard
Yang H., Yeh M., Wong G. L., Peng C., Chen C., Trinh H. N., Cheung K., Xie Q., Su T., Kozuka R., Lee D., Ogawa E., Zhao C., Ning H., Huang R., Li J., Zhang J. Q., Ide T., Xing H., Iwane S., Takahashi H., Wong C., Wong C., Lin C., Hoang J., Le A., Henry L., Toyoda H., Ueno Y., Gane E. J., Eguchi Y., Kurosaki M., Wu C., Liu C., Shang J., Furusyo N., Enomoto M., Kao J., Yuen M., Yu M. and Nguyen M. H. (20200921). Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral Therapy. : The Journal of infectious diseases.
MLA
Yang Hwai-I, Yeh Ming-Lun, Wong Grace L, Peng Cheng-Yuan, Chen Chien-Hung, Trinh Huy N, Cheung Ka-Shing, Xie Qing, Su Tung-Hung, Kozuka Ritsuzo, Lee Dong-Hyun, Ogawa Eiichi, Zhao Changqing, Ning Hui-Bin, Huang Rui, Li Jiayi, Zhang Jian Q, Ide Tatsuya, Xing Huichun, Iwane Shinji, Takahashi Hirokazu, Wong Christopher, Wong Clifford, Lin Chia-Hsin, Hoang Joseph, Le An, Henry Linda, Toyoda Hidenori, Ueno Yoshiyuki, Gane Edward J, Eguchi Yuichiro, Kurosaki Masayuki, Wu Chao, Liu Chenghai, Shang Jia, Furusyo Norihiro, Enomoto Masaru, Kao Jia-Horng, Yuen Man-Fung, Yu Ming-Lung and Nguyen Mindie H. Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral Therapy. : The Journal of infectious diseases. 20200921.